Clearmind Medicine (NASDAQ:CMND) Issues Earnings Results

Clearmind Medicine (NASDAQ:CMND) issued its quarterly earnings results on Wednesday. The company reported ($0.11) earnings per share (EPS) for the quarter, Zacks reports.

Clearmind Medicine Stock Performance

Shares of NASDAQ:CMND traded down $0.02 during midday trading on Friday, hitting $1.47. 6,903 shares of the stock were exchanged, compared to its average volume of 232,838. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.01. Clearmind Medicine has a twelve month low of $0.95 and a twelve month high of $2.30. The company has a 50 day moving average price of $1.40 and a 200-day moving average price of $1.41.

About Clearmind Medicine

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.